Skip to main navigation

About
Pipeline
Clinical Trials
Partners
News
Investors
Investor Relations
Contact

PRESS RELEASES

Webcast

Q2 2020 TRACON Pharmaceuticals Inc Earnings Conference Call

08/05/20 4:30 PM EDT

Keyword Search

Year:

08/03/20

Summary Toggle TRACON Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
Printer Friendly

PDF Version
07/29/20

Summary Toggle TRACON to Report Second Quarter 2020 Financial Results and Company Highlights on August 5, 2020
Printer Friendly

PDF Version
07/16/20

Summary Toggle TRACON Pharmaceuticals Announces Filing of Protocol for ENVASARC Pivotal Trial with the FDA
Printer Friendly

PDF Version
07/13/20

Summary Toggle TRACON Pharmaceuticals to Host Key Opinion Leader Webinar on Envafolimab for the Treatment of Sarcoma
Printer Friendly

PDF Version
06/01/20

Summary Toggle TRACON Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
Printer Friendly

PDF Version
05/29/20

Summary Toggle TRACON Pharmaceuticals Highlights Updated Envafolimab Results in MSI-H/dMMR Colorectal Cancer and Results from Clinical Trial of Opdivo and Yervoy Combination Therapy in Undifferentiated Pleomorphic Sarcoma Conducted by Alliance for Clinical Trials in Onc
Printer Friendly

PDF Version
05/14/20

Summary Toggle TRACON Pharmaceuticals Announces Presentation of Positive Clinical Data for Envafolimab in MSI-H/dMMR Cancer at ASCO 2020 Virtual Scientific Program by its Corporate Partners 3D Medicines and Alphamab
Printer Friendly

PDF Version
05/13/20

Summary Toggle TRACON Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
Printer Friendly

PDF Version
05/11/20

Summary Toggle TRACON Pharmaceuticals Announces Successful Type B Meeting with FDA for Pivotal Study of Envafolimab in Sarcoma
Printer Friendly

PDF Version
05/06/20

Summary Toggle TRACON to Report First Quarter 2020 Financial Results and Company Highlights on May 13, 2020
Printer Friendly

PDF Version

Pagination

Current page 1
Page 2
Page 3
Page 4
…
Next page
Last page

Print Page
RSS Feeds
Email Alerts
Contact

4350 La Jolla Village Drive
Suite 800
San Diego, CA 92122

Phone: (858) 550-0780
Fax: (858) 550-0786
Email: info@traconpharma.com

About

Management
Board of Directors
Scientific Advisory Board

News

Press Releases
Publications

Pipeline

Envafolimab (KN035)
TRC102
TRC253

Partners

Contact

Clinical Trials

Investors

Investor Relations

Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
- Historical Price Lookup
- Investment Calculator
Investor FAQ
Contact

Copyright © TRACON Pharmaceuticals, Inc. 2020